Skip to main content
. Author manuscript; available in PMC: 2008 Mar 17.
Published in final edited form as: Cell Immunol. 2007 Jan 25;243(1):19–29. doi: 10.1016/j.cellimm.2006.12.001

Table 2c.

CCR5 expression on CD3+ T-cells during migration across the IVBBB. This table demonstrates the CCR5 mean fluorescent intensity (MFI) on CD3+ monocytes from 5 different donors. There was a significant reduction in CCR5 MFI on T-cells following CCL5-driven migration in either the basal IVBBB or aIVBBB models relative to the input. There was no change in the MFI on non-migrated cells or cells that migrated without added CCL5 in either model relative to the input. This table in addition to the data in Figure 2a, indicates that CCR5 down-regulation on CD3+ T-cells following CCL5-driven migration is associated with a reduced receptor expression per cell.

BBB MODEL CONDITION Donor 1 Donor 2 Donor 3 Donor 4 Donor 5 p-value*
INPUT 25.8 24.4 38.0 28.2 27.9 n/a
Basal IVBBB No Chemokine-Non-migrated 25.9 24.8 37.9 27.4 22.2 n.s.
Basal IVBBB No Chemokine-Migrated 23.1 26.6 41.1 27.8 27.5 n.s.
Basal IVBBB + CCL5-Non-migrated 24.7 22.4 36.6 31.2 24.6 n.s.
Basal IVBBB + CCL5-Migrated 16.4 15.6 27.4 21.9 19.9 0.03
aIVBBB No Chemokine-Non-migrated 24.4 22.4 39.3 27.2 27.1 n.s.
aIVBBB No Chemokine-Migrated 20.8 17.0 43.3 26.4 29.8 n.s.
aIVBBB + CCL5-Non-migrated 23.8 22.3 38.5 29.8 31.1 n.s.
aIVBBB + CCL5-Migrated 15.1 15.9 26.9 19.4 18.8 0.02
*

indicates that p-values were ascertained relative to the input MFI. Key: aIVBBB: cytokine-activated in vitro blood-brain barrier, IVBBB: in vitro blood-brain barrier, n/a: not applicable, n.s.: not significant.